OBJECTIVE: To determine the relation of neonatal cranial ultrasound abnormalities to autism spectrum disorders (ASD) in low birth weight (LBW) adult survivors, a population at increased ASD risk. STUDY DESIGN: This is a secondary analysis of a prospectively-followed regional birth cohort of 1105 LBW infants systematically screened for perinatal brain injury with cranial ultrasound in the first week of life and later assessed for ASD using a two-stage process [screening at age 16 years (n = 623) followed by diagnostic assessment at age 21 years of a systematically selected subgroup of those screened (n = 189)]; 14 cases of ASD were identified. For this analysis, cranial ultrasound abnormalities were defined as ventricular enlargement (indicative of diffuse white matter injury), parenchymal lesions (indicative of focal white matter injury), and isolated germinal matrix/intraventricular hemorrhage. RESULTS: Compared with no cranial ultrasound abnormalities, any type of white matter injury (ventricular enlargement and/or parenchymal lesion) tripled the risk for screening positively for ASD [3.0 (2.2, 4.1)]. However, the risk of being diagnosed with ASD depended on type of white matter injury. With ventricular enlargement, the risk of ASD diagnosis was almost seven-fold that of no cranial ultrasound abnormality [6.7 (2.3, 19.7)], and no elevated risk was found for parenchymal lesion without ventricular enlargement [1.8 (0.2, 13.6)]. Isolated germinal matrix/intraventricular hemorrhage did not increase risk for a positive ASD screen or diagnosis. CONCLUSION: In LBW neonates, cranial ultrasound evidence of ventricular enlargement is a strong and significant risk factor for subsequent development of rigorously-diagnosed ASD.
OBJECTIVE: To determine the relation of neonatal cranial ultrasound abnormalities to autism spectrum disorders (ASD) in low birth weight (LBW) adult survivors, a population at increased ASD risk. STUDY DESIGN: This is a secondary analysis of a prospectively-followed regional birth cohort of 1105 LBW infants systematically screened for perinatal brain injury with cranial ultrasound in the first week of life and later assessed for ASD using a two-stage process [screening at age 16 years (n = 623) followed by diagnostic assessment at age 21 years of a systematically selected subgroup of those screened (n = 189)]; 14 cases of ASD were identified. For this analysis, cranial ultrasound abnormalities were defined as ventricular enlargement (indicative of diffuse white matter injury), parenchymal lesions (indicative of focal white matter injury), and isolated germinal matrix/intraventricular hemorrhage. RESULTS: Compared with no cranial ultrasound abnormalities, any type of white matter injury (ventricular enlargement and/or parenchymal lesion) tripled the risk for screening positively for ASD [3.0 (2.2, 4.1)]. However, the risk of being diagnosed with ASD depended on type of white matter injury. With ventricular enlargement, the risk of ASD diagnosis was almost seven-fold that of no cranial ultrasound abnormality [6.7 (2.3, 19.7)], and no elevated risk was found for parenchymal lesion without ventricular enlargement [1.8 (0.2, 13.6)]. Isolated germinal matrix/intraventricular hemorrhage did not increase risk for a positive ASD screen or diagnosis. CONCLUSION: In LBW neonates, cranial ultrasound evidence of ventricular enlargement is a strong and significant risk factor for subsequent development of rigorously-diagnosed ASD.
Authors: Agnes H Whitaker; Judith F Feldman; John M Lorenz; Sa Shen; Fiona McNicholas; Marlon Nieto; Dawn McCulloch; Jennifer A Pinto-Martin; Nigel Paneth Journal: Arch Pediatr Adolesc Med Date: 2006-10
Authors: Steven P Miller; Donna M Ferriero; Carol Leonard; Robert Piecuch; David V Glidden; J Colin Partridge; Marta Perez; Pratik Mukherjee; Daniel B Vigneron; A James Barkovich Journal: J Pediatr Date: 2005-11 Impact factor: 4.406
Authors: Andrew L Alexander; Jee Eun Lee; Mariana Lazar; Rebecca Boudos; Molly B DuBray; Terrence R Oakes; Judith N Miller; Jeffrey Lu; Eun-Kee Jeong; William M McMahon; Erin D Bigler; Janet E Lainhart Journal: Neuroimage Date: 2006-10-04 Impact factor: 6.556
Authors: Catherine Limperopoulos; Haim Bassan; Nancy R Sullivan; Janet S Soul; Richard L Robertson; Marianne Moore; Steven A Ringer; Joseph J Volpe; Adré J du Plessis Journal: Pediatrics Date: 2008-04 Impact factor: 7.124
Authors: Susanne Buchmayer; Stefan Johansson; Anna Johansson; Christina M Hultman; Pär Sparén; Sven Cnattingius Journal: Pediatrics Date: 2009-10-19 Impact factor: 7.124
Authors: Rebecca E Rosenberg; J Kiely Law; Gayane Yenokyan; John McGready; Walter E Kaufmann; Paul A Law Journal: Arch Pediatr Adolesc Med Date: 2009-10
Authors: Karl C K Kuban; Elizabeth N Allred; T Michael O'Shea; Nigel Paneth; Marcello Pagano; Olaf Dammann; Alan Leviton; Adré Du Plessis; Sjirk J Westra; Cindy R Miller; Haim Bassan; Kalpathy Krishnamoorthy; Joseph Junewick; Nicholas Olomu; Elaine Romano; Joanna Seibert; Steve Engelke; Padmani Karna; Daniel Batton; Sunila E O'Connor; Cecelia E Keller Journal: J Child Neurol Date: 2009-01 Impact factor: 1.987
Authors: J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta Journal: Neurotoxicology Date: 2015-12-22 Impact factor: 4.294
Authors: Carolyn Klocke; Joshua L Allen; Marissa Sobolewski; Margot Mayer-Pröschel; Jason L Blum; Dana Lauterstein; Judith T Zelikoff; Deborah A Cory-Slechta Journal: Toxicol Sci Date: 2017-04-01 Impact factor: 4.849
Authors: Enrico Danzer; Casey Hoffman; Jo Ann D'Agostino; Judith S Miller; Lindsay N Waqar; Marsha Gerdes; Judy C Bernbaum; Hannah Rosenthal; Natalie E Rintoul; Lisa M Herkert; William H Peranteau; Alan W Flake; N Scott Adzick; Holly L Hedrick Journal: J Autism Dev Disord Date: 2018-06
Authors: Aaron J Krasner; J Blake Turner; Judith F Feldman; Anna E Silberman; Prudence W Fisher; Catherine C Workman; Jonathan E Posner; Laurence L Greenhill; John M Lorenz; David Shaffer; Agnes H Whitaker Journal: J Atten Disord Date: 2015-12-23 Impact factor: 3.256